Medical professionals need to take into consideration whether or not their clients with underlying NAION risk variables may very well be adversely affected by use of PDE5 inhibitors. Individuals who have by now professional NAION are at elevated danger of NAION recurrence. Consequently, PDE5 inhibitors, such as LEVITRA, must be employed with warnin… Read More